Karen Louise Smith
About Karen Louise Smith
Karen Louise Smith is a Senior Scientist in Disease Biology at Alkermes in Dublin, Ireland, with extensive experience in pharmacology and neurodegenerative disease research.
Current Title and Role
Karen Louise Smith currently holds the position of Senior Scientist in Disease Biology at Alkermes in Dublin, Ireland. In this role, she contributes to the advancement of scientific understanding and development within the field of disease biology.
Professional Background
Karen's professional journey includes significant roles at prestigious institutions. Prior to her current position, she was a Research Scientist in Behavioral Pharmacology at Alkermes from 2014 to 2018. She also worked as a Post-doctoral Associate at both the Boston University School of Medicine (2012-2013) and Harvard Medical School (2010-2012). Additionally, Karen served as a Research Associate at the University of Pennsylvania in 2006.
Educational Background
Karen's educational foundation is anchored at Nui Galway J.E. Cairnes School of Business & Economics. She earned a Doctorate in Philosophy and Pharmacology from 2006 to 2010, a Master of Science in 2005, and a Bachelor of Science in Anatomy in 2004. She also completed a visiting PhD student program at the University of Bristol in 2007.
Research and Publications
Karen has published multiple research papers in peer-reviewed journals, focusing on disease biology and pharmacology. Her work contributes significantly to the scientific community's understanding of these fields.
Awards and Recognitions
In 2011, Karen received the 'Young Investigator Award' from the International Society for Neurochemistry, recognizing her contributions and potential in the field of neurochemistry.
Conference Presentations
Karen regularly presents her research findings at prestigious international conferences, including the Society for Neuroscience Annual Meeting. These presentations help disseminate her work to a broader scientific audience.
Mentorship and Leadership
At Alkermes, Karen actively mentors junior scientists and PhD students, fostering the next generation of researchers. She also leads cross-functional teams, notably contributing to the development of novel therapeutic approaches for neurodegenerative diseases.
Patents and Editorial Work
Karen holds a patent for a novel drug delivery system developed during her tenure at Alkermes. She also serves on the editorial board of the Journal of Neuropharmacology, guiding the publication of pioneering research in the field.